Reviewing The Case For Cemex S.A.B. De C.V. ADR (CX) Going Higher

Currently, there are 1.51B common shares owned by the public and among those 1.51B shares have been available to trade.

However, the script later moved the day high at 7.96, down -4.01%. The company’s stock has a 5-day price change of -10.62% and 11.34% over the past three months. CX shares are trading -1.16% year to date (YTD), with the 12-month market performance up to 45.63% higher. It has a 12-month low price of $4.72 and touched a high of $8.81 over the same period. CX has an average intraday trading volume of 2.08 shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.39%, -0.74%, and 7.97% respectively.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


Sponsored

Institutional ownership of Cemex S.A.B. De C.V. ADR (NYSE: CX) shares accounts for 29.57% of the company’s 1.51B shares outstanding.

It has a market capitalization of $11.58B and a beta (3y monthly) value of 1.47. The stock’s trailing 12-month PE ratio is 57.99, while the earnings-per-share (ttm) stands at $0.13. The company has a PEG of 4.26 and a Quick Ratio of 0.47 with the debt-to-equity ratio at 0.18. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.83% over the week and 3.28% over the month.

Analysts forecast that Cemex S.A.B. De C.V. ADR (CX) will achieve an EPS of $0.19 for the current quarter, $0.17 for the next quarter and $0.81 for 2024. The lowest estimate earnings-per-share for the quarter is $0.05 while analysts give the company a high EPS estimate of $0.54. Comparatively, EPS for the current quarter was -$0.12 a year ago. Earnings per share for the fiscal year are expected to increase by 2774.67%, and 12.85% over the next financial year.

Looking at the support for the CX, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on February 09, 2024, with the firm’s price target at $9.

Most Popular

Related Posts